After being diagnosed and treated for DCIS, six factors seem to be linked to a higher risk of recurrence of invasive breast cancer, according to a study.
A study suggests Black women are about 3.5 times more likely to develop lymphedema than white women.
Over the last 10 years, women of color, as well as women with less education and lower incomes, have had less access to 3D screening mammograms compared to white women and women who are more educated and well-off financially.
Latina women who've been diagnosed with breast cancer are likely to experience many gaps in care after breast cancer treatment is completed.
A study has found that the rate of heart problems after Herceptin treatment was much lower in Taiwanese women compared to results from studies looking mainly at white women.
A large percentage of the difference in breast cancer stage at diagnosis between white women and women of other ethnicities seems to be affected by whether a woman has insurance.
The genetic mutations that increase breast cancer risk, including mutations in the BRCA1, BRCA2, and PALB2 genes, are the same for both Black and white women, which means that currently available genetic tests are effective for Black women.
A study suggests that treating even early-stage breast cancer in Black women with chemotherapy before surgery can help reduce their risk of recurrence.
Expanded Medicaid coverage through the Affordable Care Act didn't seem to reduce the disparity in breast cancer death rates between Black and white women.
Black women are 2.7 times more likely to be diagnosed with triple-negative breast cancer than white women, according to a study of risk factors in more than 198,000 women.
Black women diagnosed with breast cancer who also have central obesity — excess body fat in the abdominal area — were more likely to die from breast cancer or any other cause than similar women who didn’t have central obesity.
Black women who are diagnosed with triple-negative breast cancer are 28% more likely to die from the disease than white women with the same diagnosis.
Compared to white women, Black women diagnosed with early-stage, hormone-receptor-positive disease are less likely to take hormonal therapy every day, as prescribed, or to stop taking the medicine early.
A study has found that medical mistrust is one of the biggest issues faced by Black women after breast cancer treatment.
A study suggests that estrogen-receptor-positive breast cancer cells in Black women have a very strong survival mechanism, which may be part of the reason why Black women have worse breast cancer survival rates than white women.
A study suggests that a woman's risk of breast and ovarian cancer may vary depending on the type of mutation a woman has and where the mutation is located on the BRCA1 or BRCA2 gene.
Among Black people and white people diagnosed with cancer and COVID-19, Black people had worse COVID outcomes than white people.
Breast cells in Black women express DNA repair genes differently from breast cells in white women and may be part of the reason why Black women are 41% more likely to die from breast cancer than white women.
Black and Hispanic women who had low levels of vitamin D in their blood were more likely to develop breast cancer than women with sufficient levels.
A study has found that overall rates of breast cancer in Black and white women are now about the same, but Black women older than 50 continue to be more likely to die from breast cancer than white women.
Women diagnosed with stage II or III breast cancer who have low muscle mass have worse survival rates than women with higher muscle mass.
Similar to studies in women, Black men are more likely to have more aggressive breast cancer than white men.
Research has shown that breast cancer in Black women is genetically different compared to breast cancer in white women. It's usually more aggressive and diagnosed at an earlier age and at a ...
Breast cancer rates are increasing among women, especially younger women, living in Asian countries.